טוען...
Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports
(1) Background: There is a high burden of poor glycemic control in the Indian population with type 2 diabetes mellitus (T2DM). Currently, the use of metformin sustained-release (SR)–vildagliptin fixed-dose combination (FDC) is very low as compared to metformin immediate-release (IR)–vildagliptin FDC...
| Autores principales: | , , , , |
|---|---|
| פורמט: | Online Artículo Texto |
| שפה: | English |
| יצא לאור: |
MDPI
2023
|
| נושאים: | |
| גישה מקוונת: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136586/ http://dx.doi.org/10.3390/clinpract13020045 |